Amer Hussein Muhyieddeen
Research Subjects
Amer Hussein Muhyieddeen has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Khaled Musa Mohammad Saleh
FAJR Scientific Houston Texas USA
4 shared publications - Mohammad Hashmi
UCSF Fresno, United States
4 shared publications Oune Rasheed
Near East University, Cyprus
4 shared publicationsAnkit Rathod
University of California, San Francisco–Fresno, Fresno, California
3 shared publicationsAshwini Sadhale
University of California, San Francisco–Fresno, Fresno, California
2 shared publicationsSiri Kunchakarra
University of California, San Francisco–Fresno, Fresno, California
2 shared publications
Latest Publications
- Open Access
- 18 May 2023
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 2 (3) , 100773
B-51 | Impact of COVID-19 on Transcatheter Aortic Valve Replacement Outcomes: Insight from National Inpatient Sample
- 18 May 2023
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 2 (3) , 100773
Open AccessB-51 | Impact of COVID-19 on Transcatheter Aortic Valve Replacement Outcomes: Insight from National Inpatient Sample
- Open Access
- 18 May 2023
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 2 (3) , 100698
A-34 | Utilization of Thrombolytics for STEMI During the COVID-19 Pandemic
- 18 May 2023
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 2 (3) , 100698
Open AccessA-34 | Utilization of Thrombolytics for STEMI During the COVID-19 Pandemic
- Open Access
- 18 May 2023
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 2 (3) , 100697
A-33 | Impact of COVID-19 on Percutaneous Coronary Intervention Outcomes: Insight from National Inpatient Sample
- 18 May 2023
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 2 (3) , 100697
Open AccessA-33 | Impact of COVID-19 on Percutaneous Coronary Intervention Outcomes: Insight from National Inpatient Sample
- Open Access
- 18 May 2023
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 2 (3) , 100796
C-11 | Outcomes Among Patients With Aortic Stenosis and Concurrent COVID-19 Infection
- 18 May 2023
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 2 (3) , 100796
Open AccessC-11 | Outcomes Among Patients With Aortic Stenosis and Concurrent COVID-19 Infection
- Open Access
- 22 June 2021
- Published by Houston Methodist DeBakey Heart & Vascular Center in Methodist DeBakey Cardiovascular Journal
- Vol. 17 (2) , 157-160
Supracristal Ventricular Septal Defect Complicated by Formation of an Aorto-Right Ventricular Outflow Tract Fistula: A Rare Cause of Biventricular Enlargement
Aorto-right ventricular outflow tract fistulas typically occur secondary to trauma, infective endocarditis, and sinus of Valsalva aneurysm rupture. We describe an unusual case of a spontaneous aorto-right ventricular outflow tract fistula in the absence of such findings, instead forming secondary to a complicating supracristal ventricular septal defect and leading to dilated cardiomyopathy.
- 22 June 2021
- Published by Houston Methodist DeBakey Heart & Vascular Center in Methodist DeBakey Cardiovascular Journal
- Vol. 17 (2) , 157-160
Open AccessSupracristal Ventricular Septal Defect Complicated by Formation of an Aorto-Right Ventricular Outflow Tract Fistula: A Rare Cause of Biventricular Enlargement
Aorto-right ventricular outflow tract fistulas typically occur secondary to trauma, infective endocarditis, and sinus of Valsalva aneurysm rupture. We describe an unusual case of a spontaneous aorto-right ventricular outflow tract fistula in the absence of such findings, instead forming secondary to a complicating supracristal ventricular septal defect and leading to dilated cardiomyopathy.
- Open Access
- 31 March 2021
- Published by Springer Nature in Research Square
A systematic review of patient baseline characteristics, procedural details and outcomes of combined transcatheter valvular interventions.
Background Valvular heart pathologies remain amongst the most encountered conditions surgeons and interventionists face today. Multi-valve procedures exhibit higher operative mortality than do single valve procedures, with a mortality rate that is double its counterpart. Up until recently, surgical repair was the gold standard for most diseased valves. With the advent of new percutaneous and transcatheter technologies for valve replacement, many patients deemed inoperable due to prohibitively high surgical risk have been able to benefit from these new lesser invasive techniques. Currently, one systematic review article exists by Ando et al which included 37 studies and 60 patients and demonstrated reasonable clinical outcomes in patients undergoing combined transcatheter aortic and mitral valve intervention (CTAMVI). Since that original article, many new papers and studies have been published. We purpose an updated systematic review of all cases of combined percutaneous/transcatheter multi-valvular repairs.Methods An electronic search will be performed in PubMed, EMBASE, and Cochrane through September 2020 to identify eligible observation studies and RCTs. A complete electronic search will be conducted from January 1st 2000 to September 1st 2020 with Pubmed, EMBASE and Cochrane. All search results will be uploaded to COVIDENCE and screened by title or abstract and included for full manuscript review when it’s deemed relevant to the systematic review. All data will be abstracted into a dedicated excel spreadsheet and used for further data analysis. Demographic information such as patient’s age, sex and location will be extracted. Further information such as performed procedure, surgical risk, whether procedures were done simultaneously or staged, deployed device and clinical outcomes will be extracted as well. Discussion Within the medical literature, there is limited data available regarding combined transcatheter aortic, mitral, and tricuspid valve intervention. This is an attractive alternative in high-surgical risk patients with combined valvular disease. However, its procedural details and clinical outcomes have not been well described in any current medical guidelines. Through our systematic review we will be able to better elucidate and a establish strategies for undergoing transcatheter interventions in high risk patients who require multi-valvular repair.
- 31 March 2021
- Published by Springer Nature in Research Square
Open AccessA systematic review of patient baseline characteristics, procedural details and outcomes of combined transcatheter valvular interventions.
Background Valvular heart pathologies remain amongst the most encountered conditions surgeons and interventionists face today. Multi-valve procedures exhibit higher operative mortality than do single valve procedures, with a mortality rate that is double its counterpart. Up until recently, surgical repair was the gold standard for most diseased valves. With the advent of new percutaneous and transcatheter technologies for valve replacement, many patients deemed inoperable due to prohibitively high surgical risk have been able to benefit from these new lesser invasive techniques. Currently, one systematic review article exists by Ando et al which included 37 studies and 60 patients and demonstrated reasonable clinical outcomes in patients undergoing combined transcatheter aortic and mitral valve intervention (CTAMVI). Since that original article, many new papers and studies have been published. We purpose an updated systematic review of all cases of combined percutaneous/transcatheter multi-valvular repairs.Methods An electronic search will be performed in PubMed, EMBASE, and Cochrane through September 2020 to identify eligible observation studies and RCTs. A complete electronic search will be conducted from January 1st 2000 to September 1st 2020 with Pubmed, EMBASE and Cochrane. All search results will be uploaded to COVIDENCE and screened by title or abstract and included for full manuscript review when it’s deemed relevant to the systematic review. All data will be abstracted into a dedicated excel spreadsheet and used for further data analysis. Demographic information such as patient’s age, sex and location will be extracted. Further information such as performed procedure, surgical risk, whether procedures were done simultaneously or staged, deployed device and clinical outcomes will be extracted as well. Discussion Within the medical literature, there is limited data available regarding combined transcatheter aortic, mitral, and tricuspid valve intervention. This is an attractive alternative in high-surgical risk patients with combined valvular disease. However, its procedural details and clinical outcomes have not been well described in any current medical guidelines. Through our systematic review we will be able to better elucidate and a establish strategies for undergoing transcatheter interventions in high risk patients who require multi-valvular repair.
- Open Access
- 19 March 2021
- Published by BMJ in BMJ Case Reports
- Vol. 14 (3) , e240626
Recurrent ventricular tachycardia associated with lipomatous metaplasia of a myocardial scar
Lipomatous metaplasia in chronic postmyocardial infarction scars is a common and underappreciated finding seen in histopathology and cardiac MRI. Evidence suggests that lipomatous metaplasia is capable of altering the electroconductivity of the myocardium leading to re-entry pathways that are implicated in the pathogenesis of postmyocardial infarction arrhythmogenesis. We report a case of a patient who presented with non-sustained ventricular tachycardia and was found to have lipomatous metaplasia of a prior myocardial infarct-related scar.
- 19 March 2021
- Published by BMJ in BMJ Case Reports
- Vol. 14 (3) , e240626
Open AccessRecurrent ventricular tachycardia associated with lipomatous metaplasia of a myocardial scar
Lipomatous metaplasia in chronic postmyocardial infarction scars is a common and underappreciated finding seen in histopathology and cardiac MRI. Evidence suggests that lipomatous metaplasia is capable of altering the electroconductivity of the myocardium leading to re-entry pathways that are implicated in the pathogenesis of postmyocardial infarction arrhythmogenesis. We report a case of a patient who presented with non-sustained ventricular tachycardia and was found to have lipomatous metaplasia of a prior myocardial infarct-related scar.